Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2024-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for HLB Co., Ltd. for the fiscal year ending December 31, 2023. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes (주석). While it contains an audit report, it is the full set of annual financial statements, which is the primary component of an Annual Report (10-K equivalent in the Korean market context). FY 2023
2024-03-21 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding the scheduling and details of an upcoming Investor Relations (IR) meeting. It specifies the date, time, location, and purpose of the event, and mentions that presentation materials will be posted on the exchange website. Since it is an announcement of an event rather than the presentation slides themselves, and it is under 5,000 characters, it falls under the category of a Report Publication Announcement or general regulatory filing regarding an event.
2024-03-20 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). The title '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' explicitly translates to 'Report on the Appointment, Dismissal, or Mid-term Resignation of Outside Directors'. This falls under the category of Board/Management Information as it pertains to changes in the company's board composition.
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean regulatory authority (KRX). It contains detailed financial statements, audit opinions, and financial ratios for the fiscal year. While it provides financial data, it is a specific regulatory filing format used in Korea to announce the receipt and submission of the audit report, rather than the full 10-K annual report document itself. Therefore, it is classified as an Audit Report/Information document. FY 2023
2024-03-20 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) event (Corporate Day/Conference Call). It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an upcoming investor event rather than the presentation slides themselves or a full financial report, it falls under the category of a regulatory filing announcement regarding corporate activities.
2024-03-19 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding the scheduling and details of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the event. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into other specific categories like 'Investor Presentation' (which would be the actual slides), it is classified as a Regulatory Filing (RNS) as it serves as a formal notice to the market.
2024-03-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.